✦ LIBER ✦

Serum paraoxonase 1 (PON1) lactonase activity is lower in end-stage renal disease patients than in healthy control subjects and increases after hemodialysis

✍ Scribed by Gugliucci, Alejandro; Kinugasa, Eriko; Kotani, Kazuhiko; Caccavello, Russell; Kimura, Satoshi

Book ID: 119969577
Publisher: Walter de Gruyter GmbH & Co. KG
Year: 2011
Tongue: English
Weight: 204 KB
Volume: 49
Category: Article
ISSN: 1434-6621
DOI: 10.1515/CCLM.2011.004

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Serum paraoxonase 1 (PON1) lactonase act

Serum paraoxonase 1 (PON1) lactonase activity is lower in end-stage renal disease patients than in healthy control subjects and increases after hemodialysis

✍ Gugliucci, Alejandro; Kinugasa, Eriko; Kotani, Kazuhiko; Caccavello, Russell; Ki 📂 Article 📅 2011 🏛 Walter de Gruyter GmbH & Co. KG 🌐 English ⚖ 204 KB

## Abstract **Background:** The mechanism of paraoxonase 1 (PON1) atheroprotective remains elusive. The lactonizing/lactonase activity of PON1 is gaining favor as the most significant in physiology. **Methods:** We studied 42 end-stage renal disease (ESRD) patients undergoing hemodialysis (HD) and

Serum aspirin esterase activity is lower

Serum aspirin esterase activity is lower in end-stage renal disease patients than in healthy control subjects and increases after haemodialysis

✍ Gugliucci, A.; Kotani, K.; Kinugasa, E.; Hermo, R.; Caccavello, R.; Kimura, S. 📂 Article 📅 2010 🏛 Royal Society of Medicine Press 🌐 English ⚖ 130 KB

Decreased paraoxonase 1 (PON1) lactonase

Decreased paraoxonase 1 (PON1) lactonase activity in hemodialyzed and renal transplanted patients. A novel cardiovascular biomarker in end-stage renal disease

✍ Sztanek, F.; Seres, I.; Harangi, M.; Locsey, L.; Padra, J.; Paragh, G. J. R.; As 📂 Article 📅 2012 🏛 Oxford University Press 🌐 English ⚖ 194 KB